98 related articles for article (PubMed ID: 17350821)
1. Loss of APAF-1 expression is associated with tumour progression and adverse prognosis in colorectal cancer.
Zlobec I; Minoo P; Baker K; Haegert D; Khetani K; Tornillo L; Terracciano L; Jass JR; Lugli A
Eur J Cancer; 2007 Apr; 43(6):1101-7. PubMed ID: 17350821
[TBL] [Abstract][Full Text] [Related]
2. Urokinase-type plasminogen activator is a marker of aggressive phenotype and an independent prognostic factor in mismatch repair-proficient colorectal cancer.
Minoo P; Baker K; Baumhoer D; Terracciano L; Lugli A; Zlobec I
Hum Pathol; 2010 Jan; 41(1):70-8. PubMed ID: 19740518
[TBL] [Abstract][Full Text] [Related]
3. Loss of raf-1 kinase inhibitor protein expression is associated with tumor progression and metastasis in colorectal cancer.
Minoo P; Zlobec I; Baker K; Tornillo L; Terracciano L; Jass JR; Lugli A
Am J Clin Pathol; 2007 May; 127(5):820-7. PubMed ID: 17439843
[TBL] [Abstract][Full Text] [Related]
4. Role of APAF-1, E-cadherin and peritumoral lymphocytic infiltration in tumour budding in colorectal cancer.
Zlobec I; Lugli A; Baker K; Roth S; Minoo P; Hayashi S; Terracciano L; Jass JR
J Pathol; 2007 Jul; 212(3):260-8. PubMed ID: 17516584
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
6. Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression.
Zlobec I; Baker K; Minoo P; Jass JR; Terracciano L; Lugli A
Clin Cancer Res; 2008 Jan; 14(1):143-8. PubMed ID: 18172264
[TBL] [Abstract][Full Text] [Related]
7. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
8. Role of RHAMM within the hierarchy of well-established prognostic factors in colorectal cancer.
Zlobec I; Terracciano L; Tornillo L; Günthert U; Vuong T; Jass JR; Lugli A
Gut; 2008 Oct; 57(10):1413-9. PubMed ID: 18436576
[TBL] [Abstract][Full Text] [Related]
9. Differential significance of tumour infiltrating lymphocytes in sporadic mismatch repair deficient versus proficient colorectal cancers: a potential role for dysregulation of the transforming growth factor-beta pathway.
Baker K; Zlobec I; Tornillo L; Terracciano L; Jass JR; Lugli A
Eur J Cancer; 2007 Feb; 43(3):624-31. PubMed ID: 17223543
[TBL] [Abstract][Full Text] [Related]
10. Prognostic impact of β-2-microglobulin expression in colorectal cancers stratified by mismatch repair status.
Koelzer VH; Baker K; Kassahn D; Baumhoer D; Zlobec I
J Clin Pathol; 2012 Nov; 65(11):996-1002. PubMed ID: 22859396
[TBL] [Abstract][Full Text] [Related]
11. Strategy in clinical practice for classification of unselected colorectal tumours based on mismatch repair deficiency.
Jensen LH; Lindebjerg J; Byriel L; Kolvraa S; Crüger DG
Colorectal Dis; 2008 Jun; 10(5):490-7. PubMed ID: 17868408
[TBL] [Abstract][Full Text] [Related]
12. Allelic imbalance of APAF-1 locus at 12q23 is related to progression of colorectal carcinoma.
Umetani N; Fujimoto A; Takeuchi H; Shinozaki M; Bilchik AJ; Hoon DS
Oncogene; 2004 Oct; 23(50):8292-300. PubMed ID: 15378005
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of cell cycle and apoptosis regulatory proteins in mismatch repair-proficient colorectal cancer: a tissue microarray-based approach.
Tornillo L; Lugli A; Zlobec I; Willi N; Glatz K; Lehmann F; Spichtin HP; Maurer R; Stoios D; Sauter G; Terracciano L
Am J Clin Pathol; 2007 Jan; 127(1):114-23. PubMed ID: 17145638
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas.
Le Gouvello S; Bastuji-Garin S; Aloulou N; Mansour H; Chaumette MT; Berrehar F; Seikour A; Charachon A; Karoui M; Leroy K; Farcet JP; Sobhani I
Gut; 2008 Jun; 57(6):772-9. PubMed ID: 17965063
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of mucins in colorectal cancer with different DNA mismatch-repair status.
Lugli A; Zlobec I; Baker K; Minoo P; Tornillo L; Terracciano L; Jass JR
J Clin Pathol; 2007 May; 60(5):534-9. PubMed ID: 16816167
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of the wnt signalling pathway molecules APC, beta-catenin and E-cadherin in colorectal cancer: a tissue microarray-based analysis.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Histopathology; 2007 Mar; 50(4):453-64. PubMed ID: 17448021
[TBL] [Abstract][Full Text] [Related]
17. p16INK4a polymorphism: associations with tumour progression in patients with sporadic colorectal cancer.
McCloud JM; Sivakumar R; Greenhough A; Elder J; Jones PW; Deakin M; Elder JB; Fryer AA; Hoban PR
Int J Oncol; 2004 Nov; 25(5):1447-52. PubMed ID: 15492837
[TBL] [Abstract][Full Text] [Related]
18. A simple and reproducible scoring system for EGFR in colorectal cancer: application to prognosis and prediction of response to preoperative brachytherapy.
Zlobec I; Vuong T; Hayashi S; Haegert D; Tornillo L; Terracciano L; Lugli A; Jass J
Br J Cancer; 2007 Mar; 96(5):793-800. PubMed ID: 17311026
[TBL] [Abstract][Full Text] [Related]
19. Systematic assessment of protein phenotypes characterizing high-grade tumour budding in mismatch repair-proficient colorectal cancer.
Karamitopoulou E; Lugli A; Panayiotides I; Karakitsos P; Peros G; Rallis G; Patsouris ES; Terracciano L; Zlobec I
Histopathology; 2010 Aug; 57(2):233-43. PubMed ID: 20716165
[TBL] [Abstract][Full Text] [Related]
20. Molecular analysis of colorectal cancer tumors from patients with mismatch repair proficient hereditary nonpolyposis colorectal cancer suggests novel carcinogenic pathways.
Sánchez-de-Abajo A; de la Hoya M; van Puijenbroek M; Tosar A; López-Asenjo JA; Díaz-Rubio E; Morreau H; Caldes T
Clin Cancer Res; 2007 Oct; 13(19):5729-35. PubMed ID: 17908962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
